Introducing the world's first online tool to identify and aggregate an
organization's research output portfolio
The Scopus Affiliation Identifier Phase 1 facilitates faster
decision-making
Introducing the world's first online tool to identify and aggregate an
organization's research output portfolio.
The Scopus Affiliation Identifier Phase 1 facilitates faster
decision-making
Amsterdam, The Netherlands - December13, 2007 - Scopus(r), the world's
largest abstract and citation database of peer-reviewed literature,
today announced that a sought after literature research tools, the
Scopus Affiliation Identifier Phase 1 will be launched in January. This
new feature will speed up the search process by enabling users to find
all the documents belonging to a specific organization. Doing so will
save users valuable time which can be better invested in performing the
actual research analysis.
The Scopus Affiliation Identifier Phase 1 is a unique tool which
automatically identifies and matches an organization with all its
research output. Scopus is the first to offer its customers this
organizational matching functionality across its entire database of over
15,000 peer reviewed journals. This will be welcome news for deans,
faculty heads, researchers and funding bodies who understand just how
difficult and time-consuming this task has been up to now.
Using a combination of sophisticated algorithms and a comprehensive
knowledge base, the Scopus Affiliation Identifier Phase 1 will quicken
the rate at which data can be collated for research performance
measurement at the institutional level. The feature automatically
matches the multiple name variants attributed to an organization. This
is extremely useful where several name variants of an organization may
exist or may be recorded differently by publishing authors. One such an
example is the Massachusetts Institute of Technology where articles
found in Scopus and published by authors belonging to this institute
carry more than 1,700 name variants. Other reasons for these numbers of
variations can be attributed to organizations changing their name,
having similar names, or they may merge or separate. This can make it
challenging to clearly identify a single organization's complete body of
work.
"Up until now we have had to employ personnel to carry out this mammoth
task. It is both a slow and expensive process. The Scopus Affiliation
Identifier Phase 1 produces the same results in significantly less time.
This not only helps us to reduce the number of staff but also allows us
to focus on research analysis rather than data collection and filtering
activities." says David Clay is Deputy Head of Academic Liaison and
Finance at the University of Liverpool. The Scopus Affiliation
Identifier Phase 1 makes it easier for him to evaluate his own
institution and others.
Users will benefit immediately from the initial version of the Scopus
Affiliation Identifier Phase 1, available in January. The next phase,
scheduled for release in the first half of 2008, will offer users
enhanced functionalities. Scopus is actively soliciting feedback from
individual organizations in order to enhance the data clarity.
"We are delighted to be able to introduce the Scopus Affiliation
Identifier Phase 1 to the market," says Niels Weertman, Director Product
Management Scopus. "We've invested heavily in developing a feature that
will deliver significant time and cost benefits to our users. Ultimately
it will help deans, chancellors and faculty heads make resource
allocation and strategic planning decisions more efficiently."
For further information on Scopus or the Scopus Affiliation Identifier
Phase 1, please visit: www.info.scopus.com/affiliationidentifier.
For feedback on the Scopus Affiliation Identifier, please contact:
affiliationfeedback@scopus.com.
Alternatively you can contact:
Lauren Hillman, Fusion Public Relations
T: +1 202 898 2000, ext. 117
E: lauren.hillman@fusionpr.com <mailto:nickludlum@fusionpr.com>
About Scopus
Covering the world's research literature, Scopus is the largest abstract
and citation database of peer-reviewed literature and quality Web
sources with smart tools to track, analyze and visualize research.
Scopus is designed and developed with over 500 users and librarians
internationally. Its unique database contains abstracts and references
from over 15,000 peer-reviewed journals from 4,000 publishers worldwide,
ensuring broad interdisciplinary coverage. In addition, Scopus not only
offers users citation information about the articles covered, but also
integrates Web and patent searches directly from its clean and simple
interface. Direct links to full-text articles, library resources and
other applications like reference management software, make Scopus
quicker, easier and more comprehensive to use than any other literature
research tool. For more information about Scopus please visit
www.info.scopus.com.
<http://www.info.scopus.com/news/press/www.info.scopus.com.>
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees in
over 70 offices worldwide publish more than 2,000 journals and 1,900 new
books per year, in addition to offering a suite of innovative electronic
products, such as ScienceDirect (http://www.sciencedirect.com/), MD
Consult (http://www.mdconsult.com/), Scopus
(http://www.info.scopus.com/), bibliographic databases and online
reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered
in Amsterdam, The Netherlands and has offices worldwide. Elsevier is
part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a
world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business sectors,
Reed Elsevier provides high-quality and flexible information solutions
to users, with increasing emphasis on the Internet as a means of
delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
xxx